| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/04/2000 | WO1999067283A8 Two-kinase domain mitogen- and stress-activated protein kinases and uses thereof |
| 05/04/2000 | WO1999066036A9 Transplants for myocardial scars |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | WO1999043672A9 Inhibitors of phospholipase a2 |
| 05/04/2000 | DE19850131A1 Chromenon- und Chromanonderivate Chromenon- and chromanone |
| 05/04/2000 | DE19850072A1 Phosphinat-Peptidanaloga zur Behandlung von fibrotischen Erkrankungen Phosphinate-peptide analogues in the treatment of fibrotic diseases |
| 05/04/2000 | CA2349211A1 Prv-1 gene and the use thereof |
| 05/04/2000 | CA2348989A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 05/04/2000 | CA2348833A1 Human phospholipases |
| 05/04/2000 | CA2348576A1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 05/04/2000 | CA2348165A1 Dihydropyridine compounds and methods of use |
| 05/04/2000 | CA2348160A1 Use of antifungal agents for treating scleroses |
| 05/04/2000 | CA2348023A1 Benzoazepines and analogs thereof useful as growth hormone secretagogues |
| 05/04/2000 | CA2347028A1 Systems and compounds for drug delivery to interstitial regions of the myocardium |
| 05/04/2000 | CA2346990A1 Serine protease inhibitor |
| 05/04/2000 | CA2344606A1 Conformation-specific anti-von willebrand factor antibodies |
| 05/04/2000 | CA2343100A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
| 05/04/2000 | CA2342626A1 Substituted phenyl derivatives, their preparation and use |
| 05/04/2000 | CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/03/2000 | EP0997474A1 Antithrombotic agents |
| 05/03/2000 | EP0997464A1 1,3,8-Triazaspiro[4,5] decanone compounds as orl1-receptor agonists |
| 05/03/2000 | EP0996637A1 Recombinant protein c and protein s variants |
| 05/03/2000 | EP0996623A1 2,6-DI-t-BUTYL-4- (DIMETHYL-4-METHOXYPHENYLSILYL) -METHYLOXY]PHENOL AND 2,6-DI-t-BUTYL-4- (DIMETHYL-2-METHOXY-PHENYLSILYL) -METHYLOXY]PHENOL |
| 05/03/2000 | EP0996621A1 Novel compounds |
| 05/03/2000 | EP0996620A1 Novel compounds |
| 05/03/2000 | EP0996618A1 Endothelin antagonists: n- 2'- (4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl) 1,1'-biphenyl]-2-yl]methyl] -n,3,3-trimethylbutanamide and n-(4,5-dimethyl-3-isoxazolyl) -2'- (3,3-dimethyl-2-oxo-1-pyrrolidinyl) methyl] -4'-(2-oxazolyl) 1,1'-biphenyl]-2-sulfonamide and salts thereof |
| 05/03/2000 | EP0996612A2 Aliphatic propargylamines as cellular rescue agents |
| 05/03/2000 | EP0996463A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
| 05/03/2000 | EP0996459A1 Use of exendins and agonists thereof for the reduction of food intake |
| 05/03/2000 | EP0996454A1 Polyallylamine polymers for treating hypercholesterolemia |
| 05/03/2000 | EP0996446A1 Novel substituted imidazole compounds |
| 05/03/2000 | EP0996445A1 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |
| 05/03/2000 | EP0996443A1 Certain diarylimidazole derivatives; a new class of npy specific ligands |
| 05/03/2000 | EP0996440A1 Method for treatment of glutamate related disorders |
| 05/03/2000 | EP0996435A1 Amino acid derivatives useful to treat stroke |
| 05/03/2000 | EP0996433A1 Methods for treatment of conditions associated with lactosylceramide |
| 05/03/2000 | EP0996431A1 Synergistic compositions of lycopene and vitamin e for the prevention of ldl oxidation |
| 05/03/2000 | EP0788474B1 Nitro-benzamides useful as anti-arrhythmic agents |
| 05/03/2000 | EP0754043B1 Inhibition of smooth muscle cell migration by (r)-amlodipine |
| 05/03/2000 | EP0691985B1 Phosphonomethyldipeptides |
| 05/03/2000 | CN1252070A 5,7-disubstituted 4-aminopyrido [2,3,-d] pyrimidine compounds and their use as adenosine kinase inhibitors |
| 05/03/2000 | CN1252069A 5,6,7-trisubstituted-4-aminopyrido [2,3-d] pyrimidine compounds |
| 05/03/2000 | CN1252068A 3-piperidyl-4-oxoquinazoline derivatives and medicinal compositions containing same |
| 05/03/2000 | CN1252064A Bicyclic amino acids |
| 05/03/2000 | CN1252057A 2-amino substituted pyridines for treating arteriosclerosis and hyperlipoproteinaemia |
| 05/03/2000 | CN1252053A Cetp activity inhibitors |
| 05/03/2000 | CN1252049A 2-substituted benzoyl-cycloalkyl-1-carboxylic acid derivatives |
| 05/03/2000 | CN1251760A Medicine |
| 05/03/2000 | CN1251745A Carotenoid preparation having mixture of beta-carotene, lycopene and xanthophyll |
| 05/03/2000 | CN1052006C Vasocontrictive dihydrobenzopyran derivatives, preparation and use thereof |
| 05/03/2000 | CN1051991C Preparation of glutaric acid derivatives |
| 05/03/2000 | CN1051927C Navel medicine bag for treatment of hypertension and cerebral arteriosclerosis and preparation |
| 05/03/2000 | CN1051921C Methods of inhibiting imperfect tissue repair |
| 05/02/2000 | US6057457 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase |
| 05/02/2000 | US6057454 1-oxo-1H-inden-2-yl-1H-imidazole-2-carboxylic acid intermediates |
| 05/02/2000 | US6057441 Cardiovascular disorders and gastrointestinal disorders |
| 05/02/2000 | US6057440 Process for preparing bis-indoly macrocycles |
| 05/02/2000 | US6057344 Methods for treating hypertension, and angina using optically pure (-) amlodipine |
| 05/02/2000 | US6057338 Useful in the treatment of diabetes, cancer, acromegaly, restenosis, depression, irritable bowel syndrome, pain and diabetic retinopathy |
| 05/02/2000 | US6057336 Lactam metalloprotease inhibitors |
| 05/02/2000 | US6057332 Substituted 1,4-dihydropyrimidine-5-carboxylate compounds, their preparation and uses |
| 05/02/2000 | US6057321 1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application |
| 05/02/2000 | US6057318 Heterocyclic derivatives, process for their preparation and their therapeutic use |
| 05/02/2000 | US6057317 Heterocyclic compounds |
| 05/02/2000 | US6057301 Moisture resistant, improved storage stability |
| 05/02/2000 | US6057300 Introducing expression vector comprising gene encoding p21 and expression vector comprising second gene encoding immunotherapeutic agent, genetic therapeutic, cytokine or prodrug converting enzyme to treat restenosis |
| 05/02/2000 | US6057295 Oligopeptides derived from C-reactive protein fragments |
| 05/02/2000 | US6057294 Peptide |
| 05/02/2000 | US6057287 Kallikrein-binding "Kunitz domain" proteins and analogues thereof |
| 05/02/2000 | US6055936 Sea cucumber carotenoid lipid fractions and process |
| 05/02/2000 | CA2115427C Novel 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 05/02/2000 | CA2076018C Docosahexaenoic acid, methods for its production and compounds containing the same |
| 05/02/2000 | CA2069961C Method and compositions for inhibition of disorders associated with oxidative damage |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 04/27/2000 | WO2000023572A1 Tnfr related gene 12 |
| 04/27/2000 | WO2000023570A1 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 04/27/2000 | WO2000023565A2 Novel neuropilin/growth factor binding and uses thereof |
| 04/27/2000 | WO2000023546A1 Method of extracting lipids from marine and aquatic animal tissues |
| 04/27/2000 | WO2000023472A2 Interferon-beta fusion proteins and uses |
| 04/27/2000 | WO2000023459A1 Inhibitors of platelet activation and recruitment |
| 04/27/2000 | WO2000023457A1 Adenine derivatives |
| 04/27/2000 | WO2000023451A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023447A1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties |
| 04/27/2000 | WO2000023445A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023438A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/27/2000 | WO2000023426A1 Novel imidazoles with anti-inflammatory activity |
| 04/27/2000 | WO2000023425A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023421A1 (SUBSTITUTED)ACYL DIPEPTIDYL INHIBITORS OF THE ICE/ced-3 FAMILY OF CYSTEINE PROTEASES |
| 04/27/2000 | WO2000023417A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023416A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023415A1 New compounds, their preparation and use |
| 04/27/2000 | WO2000023407A2 Ureido-thiobutyric acid derivatives as ppar-agonists |
| 04/27/2000 | WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L |
| 04/27/2000 | WO2000023114A2 Polymer conjugates of interferon beta- 1a and their uses |
| 04/27/2000 | WO2000023113A1 Peptide-based carrier devices for stellate cells |
| 04/27/2000 | WO2000023100A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | WO2000023094A2 Methods of inhibiting platelet activation and recruitment |
| 04/27/2000 | WO2000023092A1 Contulakin-g, analogs thereof and uses therefor |
| 04/27/2000 | WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |